UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
Commission File Number |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices)
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading symbol(s) |
Name of each exchange on which registered | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
CURRENT REPORT ON FORM 8-K
| Item 1.01 | Entry into a Material Definitive Agreement |
On August 12, 2024, New York Community Bancorp, Inc. (the “Company” or “NYCB”) entered into separate share exchange agreements with (a) affiliates of funds managed by Liberty 77 Capital L.P. (“Liberty”), (b) affiliates of funds managed by Hudson Bay Capital Management, LP (“Hudson Bay”) and (c) affiliates of funds managed by Reverence Capital Partners, L.P. (“Reverence” and, collectively with Liberty and Hudson Bay, the “Investors”, and each of the share exchange agreements entered into with each of the Investors on August 12, 2024, an “Exchange Agreement,” and, collectively, the “Exchange Agreements”).
Pursuant to the terms of each Investor’s respective Exchange Agreement, on August 12, 2024, (a) Liberty exchanged 29,000 shares of Series B Noncumulative Convertible Preferred Stock of the Company, par value $0.01 per share (“Series B Preferred Stock”), for the issuance by the Company of 9,666,665 shares of common stock of the Company, par value $0.01 per share (“Common Stock”), to Liberty; (b) Hudson Bay exchanged 22,500 shares of Series B Preferred Stock for the issuance by the Company of 7,499,998 shares of Common Stock to Hudson Bay; and (c) Reverence exchanged 11,857 shares of Series B Preferred Stock for the issuance by the Company of 3,952,332 shares of Common Stock to Reverence (each an “Exchange,” and, collectively, the “Exchanges”). The number of shares of Series B Preferred Stock of each Investor so exchanged is an amount such that no Investor (together with its affiliates) would beneficially own in excess of 9.99% of the shares of Common Stock outstanding immediately following the Exchanges. All of the Exchanges were consummated simultaneously.
Each of the Investors acquired the shares of Series B Preferred Stock that were exchanged for shares of Common Stock in the applicable Exchange on March 11, 2024 as part of the Company’s approximately $1.05 billion capital raise transaction pursuant to separate investment agreements entered into with each of the Investors on March 7, 2024, each of which was amended on March 11, 2024 (collectively, the “Investment Agreements”). Each share of Series B Preferred Stock is automatically convertible into shares of Common Stock (or, in limited circumstances, a share of Series C Noncumulative Preferred Stock of the Company) in a transfer by the holder thereof consistent with the rules and limitations of Regulation Y of the Bank Holding Company Act of 1956, as amended. The Investment Agreements contemplated that the Company, on the one hand, and each individual Investor, on the other hand, would cooperate in good faith to effect exchanges of shares of Series B Preferred Stock for shares of Common Stock, subject to receipt of certain approvals. The Investment Agreements, along with (i) a Registration Rights Agreement, dated March 11, 2024, entered into by the Company with the Investors and the other investors in such capital raise and (ii) warrants issued by the Company to the Investors and the other investors in such capital raise pursuant to which the holder may acquire capital stock of the Company, were disclosed and described in the Company’s Current Report on Form 8-K filed on March 14, 2024 and in the Company’s definitive proxy statement filed on April 26, 2024.
Immediately following the Exchanges, (a) Liberty held 114,355 shares of Series B Preferred Stock, which are (in the aggregate) convertible into approximately 38,118,329 shares of Common Stock; (b) Hudson Bay held 14,350 shares of Series B Preferred Stock, which are (in the aggregate) convertible into approximately 4,783,332 shares of Common Stock; and (c) Reverence held no shares of Series B Preferred Stock.
As of the close of business on August 12, 2024 (and after giving effect to the Exchanges), the number of shares of Common Stock outstanding was 372,551,600 shares.
The foregoing description of the Exchange Agreements is qualified in its entirety by reference to the full text of the form of Exchange Agreement, which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits.
| 10.1 | Form of Exchange Agreement* | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
| * | Pursuant to Item 601(a)(5) of Regulation S-K, certain schedules and similar attachments have been omitted. The registrant hereby agrees to furnish a copy of any omitted schedule or similar attachment to the SEC upon request. |
Cautionary Note Regarding Forward-Looking Statements
This Current Report on Form 8-K may include forward-looking statements within the meaning of the federal securities laws by NYCB pertaining to such matters as our goals, intentions, and expectations regarding (a) revenues, earnings, loan production, asset quality, liquidity position, capital levels, risk analysis, divestitures, acquisitions, and other material transactions, among other matters; (b) the future costs and benefits of the actions we may take; (c) our assessments of credit risk and probable losses on loans and associated allowances and reserves; (d) our assessments of interest rate and other market risks; (e) our ability to execute on our strategic plan, including the sufficiency of our internal resources, procedures and systems; (f) our ability to attract, incentivize and retain key personnel and the roles of key personnel; (g) our ability to achieve our financial and other strategic goals, including those related to our merger with Flagstar Bancorp, Inc., which was completed on December 1, 2022, our acquisition of substantial portions of the former Signature Bank through an FDIC-assisted transaction, and our ability to fully and timely implement the risk management programs institutions greater than $100 billion in assets must maintain; (h) the effect on our capital ratios of the approval of certain proposals approved by our shareholders during the 2024 annual meeting of our shareholders; (i) the conversion or exchange of shares of the Company’s preferred stock, including receipt of required regulatory approvals necessary or desirable to effect further exchanges; and (j) the payment of dividends on shares of the Company’s capital stock, including adjustments to the amount of dividends payable on shares of the Company’s preferred stock.
Forward-looking statements are typically identified by such words as “believe,” “expect,” “anticipate,” “intend,” “plan,” “outlook,” “estimate,” “forecast,” “project,” “should,” and other similar words and expressions, and are subject to numerous assumptions, risks, and uncertainties, which change over time. Additionally, forward-looking statements speak only as of the date they are made; the Company does not assume any duty, and does not undertake, to update our forward-looking statements. Furthermore, because forward-looking statements are subject to assumptions and uncertainties, actual results or future events could differ, possibly materially, from those anticipated in our statements, and our future performance could differ materially from our historical results.
Our forward-looking statements are subject to, among others, the following principal risks and uncertainties: general economic conditions and trends, either nationally or locally; conditions in the securities, credit and financial markets; changes in interest rates; the inability of the Company’s wholly-owned subsidiary, Flagstar Bank, N.A., and Nationstar Mortgage LLC to execute the transaction contemplated by the MSR Purchase Agreement and Asset Purchase Agreement or satisfy customary closing conditions in connection therewith; changes in deposit flows, and in the demand for deposit, loan, and investment products and other financial services; changes in real estate values; changes in the quality or composition of our loan or investment portfolios, including associated allowances and reserves; changes in future allowance for credit losses requirements under relevant accounting and regulatory requirements; the ability to pay future dividends; changes in our capital management and balance sheet strategies and our ability to successfully implement such strategies; changes in our strategic plan, including changes in our internal resources, procedures and systems, and our ability to successfully implement such plan; changes in competitive pressures among financial institutions or from non-financial institutions; changes in legislation, regulations, and policies; the success of our blockchain and fintech activities, investments and strategic partnerships; the restructuring of our mortgage business; the impact of failures or disruptions in or breaches of the Company’s operational or security systems, data or infrastructure, or those of third parties, including as a result of cyberattacks or campaigns; the impact of natural disasters, extreme weather events, military conflict (including the Russia/Ukraine conflict, the conflict in Israel and surrounding areas, the possible expansion of such conflicts and potential geopolitical consequences), terrorism or other geopolitical events; and a variety of other matters which, by their nature, are subject to significant uncertainties and/or are beyond our control. Our forward-looking statements are also subject to the following principal risks and uncertainties with respect to our merger with Flagstar Bancorp, which was completed on December 1, 2022, and our acquisition of substantial portions of the former Signature Bank through an FDIC-assisted transaction: the possibility that the anticipated benefits of the transactions will not be realized when expected or at all; the possibility of increased legal and compliance costs, including with respect to any litigation or regulatory actions related to the business practices of acquired companies or the combined business; diversion of management’s attention from ongoing business operations and opportunities; the possibility that the Company may be unable to achieve expected synergies and operating efficiencies in or as a result of the transactions within the expected timeframes or at all; and revenues following the transactions may be lower than expected. Additionally, there can be no assurance that the Community Benefits Agreement entered into with NCRC, which
was contingent upon the closing of the Company’s merger with Flagstar Bancorp, Inc., will achieve the results or outcome originally expected or anticipated by us as a result of changes to our business strategy, performance of the U.S. economy, or changes to the laws and regulations affecting us, our customers, communities we serve, and the U.S. economy (including, but not limited to, tax laws and regulations).
More information regarding some of these factors is provided in the Risk Factors section of our Annual Report on Form 10-K/A for the year ended December 31, 2023, Quarterly Report on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024 and in other SEC reports we file. Our forward-looking statements may also be subject to other risks and uncertainties, including those we may discuss in this Amendment, during investor presentations, or in our other SEC filings, which are accessible on our website and at the SEC’s website, www.sec.gov.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: August 13, 2024 | NEW YORK COMMUNITY BANCORP, INC. | |||||
| /s/ Salvatore J. DiMartino | ||||||
| Salvatore J. DiMartino | ||||||
| Executive Vice President | ||||||
| Director of Investor Relations | ||||||
Exhibit 10.1
SHARE EXCHANGE AGREEMENT
This SHARE EXCHANGE AGREEMENT (this “Agreement”) is entered into as of August 12, 2024, by and between New York Community Bancorp, Inc., a Delaware corporation (the “Company”), and [Stockholder] (the “Stockholder”). Capitalized terms used (but not defined) herein shall have the meanings ascribed to them in that certain Investment Agreement, dated as of March 7, 2024 (as amended, modified or supplemented from time to time in accordance with its terms, including on March 11, 2024, the “Investment Agreement”), by and between the Company and the Stockholder.
RECITALS
WHEREAS, as of the date hereof, the Stockholder is the owner of [•] issued and outstanding shares of the Company’s Series B Noncumulative Convertible Preferred Stock, par value $0.01 per share (the “Series B Preferred Stock”);
WHEREAS, the Stockholder and the Company desire that (a) the Stockholder transfer, deliver, convey and assign [•] shares of Series B Preferred Stock (the “Shares”) to the Company and (b) the Company issue to the Stockholder [•] shares of Common Stock (the “Exchange Shares”) in exchange for the Shares (the “Exchange”), all pursuant to the terms and conditions set forth in this Agreement; and
WHEREAS, concurrently with the entry into this Agreement, the Company is entering into substantially similar separate agreements with certain other holders of Series B Preferred Stock (collectively, the “Other Stockholders”) in respect of the exchange (collectively, the “Other Exchanges”) by each such Other Stockholder of shares of Series B Preferred Stock owned by such Other Stockholder for shares of Common Stock (collectively, the “Other Exchange Documents”).
NOW THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants, agreements and conditions hereinafter set forth, and intending to be legally bound hereby, the parties agree as follows:
ARTICLE 1
EXCHANGE
1.1 Delivery and Assignment of Series B Preferred Stock. At the Closing (as defined below), contemporaneously with the Other Exchanges, the Stockholder shall transfer, deliver, convey and assign to the Company, free and clear of all Liens (other than transfer restrictions imposed under the Certificate of Designations (Series B), the Permanent Warrant or applicable securities Laws), the Shares in exchange for the Exchange Shares, at which time the Shares shall be canceled and retired and revert to authorized but unissued shares of preferred stock of the Company, and Stockholder shall thereafter have no right, title or interest in the Shares. For the avoidance of doubt, the transfer of the Shares shall be evidenced by book-entry notation.
1.2 Issuance of Exchange Shares. Contemporaneously with the Stockholder’s delivery of the Shares to the Company pursuant to Section 1.1, the Company shall issue and deliver, or cause to be issued and delivered, the Exchange Shares to the Stockholder free and clear of all Liens (other than transfer restrictions imposed under applicable securities Laws or the Permanent Warrant). For the avoidance of doubt, the issuance of the Exchange Shares shall be evidenced by book-entry notation and the Company shall provide such evidence to the Stockholder promptly following the Closing.
1.3 Closing. The closing of the Exchange (the “Closing”) shall be effective as of the date hereof and occur simultaneously with (a) the execution hereof and (b) the execution of the Other Exchange Documents and the closing of the exchanges of Series B Preferred Stock for shares of Common Stock contemplated thereby (collectively, the “Other Closings”), remotely via the exchange of documents and signatures, unless another place, time or date is agreed to in writing by the parties. All deliveries to be made or other actions to be taken at the Closing shall be deemed to occur simultaneously, and no such delivery or action shall be deemed complete until all such deliveries and actions have been completed or the relevant parties have agreed to waive such delivery or action. If the Closing does not occur, or any Other Closing does not occur, any delivery made or other action taken at the Closing shall be deemed not to have occurred and be without force or effect.
ARTICLE 2
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company hereby represents and warrants to the Stockholder as of the date hereof that:
2.1 Organization. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and is a bank holding company duly registered under the BHC Act.
2.2 Authority. The Company has full corporate power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the Closing. The execution, delivery and performance by the Company of this Agreement and the consummation of the Exchange have been duly authorized by all necessary corporate action on the part of the Company, and no further corporate approval or authorization is required on the part of the Company to enter into this Agreement or effect the Exchange. This Agreement has been duly and validly executed and delivered by the Company and (assuming due authorization, execution and delivery by the Stockholder) and constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as the same may be limited by the Enforceability Exceptions.
2.3 No Violation. None of the execution and delivery of this Agreement by the Company, the performance by the Company of its obligations hereunder, the consummation by the Company of the Exchange, or compliance by the Company with any of the terms or provisions hereof, will (A) violate any provision of the Company Certificate of Incorporation or the Company Bylaws or (B) (x) violate any Law applicable to the Company, any of its Subsidiaries or any of their respective properties or assets or (y) violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance
2
required by, or result in the creation of any Lien upon any of the respective properties or assets of the Company or any of its Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Company or any of its Subsidiaries is a party, or by which they or any of their respective properties or assets may be bound, except (in the case of clauses (B)(x) and (B)(y) above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or creations which would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
2.4 Valid Issuance of Shares. All of the Exchange Shares have been duly authorized by all necessary corporate action on the part of the Company and, when issued pursuant to this Agreement upon receipt by the Company of the Shares in exchange therefor, will be validly issued, fully paid and nonassessable and free and clear of all Liens (other than transfer restrictions imposed under applicable securities Laws or the Permanent Warrant), and no current or past stockholder of the Company will have any preemptive right or similar rights in respect thereof. The Exchange Shares shall be issued in compliance with applicable securities Laws.
2.5 No Brokers or Finders. No person has or will have, as a result of any act or omission of the Company, any right, interest or claim against or upon the Company for any commission, fee or other compensation as a finder or broker, or in any similar capacity, in connection with the transactions contemplated by this Agreement.
2.6 Consents and Approvals. No consent, approval, waiver, exemption, authorization, notice, registration, declaration or filing is required to be obtained by or from, or to be given by the Company to, or made by the Company with, any Governmental Entity in connection with the execution, delivery and performance by the Company of this Agreement (including to issue the Exchange Shares).
2.7 Holding Period. For the purposes of Rule 144 of the Securities Act, the Company hereby acknowledges and agrees that (a) the holding period of the Shares may be tacked onto the holding period of the Exchange Shares received in respect of such Shares and (b) it will not take a position contrary to clause (a) above.
2.8 Most Favored Nation.
(a) None of the terms offered to any Other Stockholder (including, without limitation, with respect to the reimbursement of legal fees and expenses) with respect to any exchange, conversion or repurchase of Series B Preferred Stock pursuant to any (i) Other Exchange Document or (ii) other contract, agreement, arrangement or understanding entered into with such Other Stockholder in connection with the exchange contemplated by the applicable Other Exchange Document (clause (i) and (ii), collectively, the “Exchange Documents”) are more favorable to such Other Stockholder than the terms of the Stockholder under this Agreement and any other contract, agreement, arrangement or understanding entered into with the Stockholder in connection with the Exchange (it being understood and agreed that the number of shares of Series B Preferred Stock that each Other Stockholder is exchanging under the applicable Other Exchange Document varies from the number of the Shares).
3
(b) From and after the entry hereof, the Company will not amend, supplement, restate or amend and restate (or waive any provision of) any Exchange Document in a manner more favorable to any Other Stockholder (including, without limitation, with respect to the reimbursement of legal fees and expenses) than the terms in this Agreement or any other contract, agreement, arrangement or understanding entered into with the Stockholder in connection with the Exchange (as applicable).
2.9 Capitalization.
(a) As of August 9, 2024, there were 351,432,605 shares of Common Stock issued and outstanding (for the avoidance of doubt, excluding treasury shares).
(b) 63,357 shares of Series B Preferred Stock (in the aggregate) are being exchanged for 21,118,995 shares of Common Stock (in the aggregate) pursuant to the Exchange and the Other Exchanges.
(c) Immediately following completion of the Exchange and the Other Exchanges, there will be no less than 372,551,600 shares of Common Stock issued and outstanding (for the avoidance of doubt, excluding treasury shares).
ARTICLE 3
REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDER
The Stockholder hereby represents and warrants to the Company as of the date hereof that:
3.1 Organization. The Stockholder is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization.
3.2 Authority. The Stockholder has the corporate, partnership or limited liability (as applicable) power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the Closing. The execution, delivery and performance by the Stockholder of this Agreement and the consummation of the Exchange have been duly authorized by all necessary organizational action on the part of the Stockholder, and no further organizational approval or authorization is required on the part of the Stockholder to enter into this Agreement or effect the Exchange. This Agreement been duly and validly executed and delivered by the Stockholder and (assuming due authorization, execution and delivery by the Company) and constitutes a valid and binding on the Stockholder and enforceable against the Stockholder in accordance with its terms, except as the same may be limited by the Enforceability Exceptions.
3.3 No Violation. None of the execution and delivery of this Agreement by the Stockholder, the performance by the Stockholder of its obligations hereunder, the consummation by the Stockholder of the Exchange, or compliance by the Stockholder with any of the terms or provisions hereof, will (A) violate any provision of the Stockholder’s organizational documents or (B) (x) violate any Law applicable to the Stockholder or any of its properties or assets or (y) violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a
4
default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of its properties or assets under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Stockholder is a party, or by which the Stockholder or any of its properties or assets may be bound, except (in the case of clauses (B)(x) and (B)(y) above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or creations which would not, either individually or in the aggregate, reasonably be expected to materially and adversely affect the Stockholder’s ability to consummate the Exchange and the other transactions contemplated by this Agreement.
3.4 Title to Shares. The Stockholder (a) directly holds all of the Shares and (b) has good, valid and marketable title to the Shares, free and clear of any Liens (other than transfer restrictions (i) imposed under the Certificate of Designations (Series B), the Permanent Warrant or applicable securities Laws or (ii) that the Stockholder may have created in favor of a prime broker under and in accordance with its prime brokerage agreement with such broker (which such prime brokerage agreement is not primarily in respect of the Shares), which are of a customary nature).
3.5 Consents and Approvals.
(a) No consent, approval, waiver, exemption, authorization, notice, registration, declaration or filing (other than any filing required under Section 13 or Section 16 of the Securities Exchange Act of 1934, as amended) is required to be obtained by or from, or to be given by the Stockholder to, or made by the Stockholder with, any Governmental Entity in connection with the execution, delivery and performance by the Stockholder of this Agreement (including to acquire the Exchange Shares).
(b) The Stockholder is not aware of any facts, events or circumstances that, upon consummation of the transactions contemplated herein, would reasonably be expected to cause the Stockholder or any of its affiliates to be presumed to “control” the Company or Company Bank for purposes of the BHC Act.
3.6 Acknowledgement. The Stockholder acknowledges and agrees that it (a) is acquiring the Exchange Shares pursuant to an exemption from registration under the Securities Act for its own account or for one or more separate accounts maintained by it for the benefit of one or more other Institutional Accredited Investors and not with a view to the distribution thereof in violation of any securities Laws; provided that the disposition of the Stockholder’s property shall at all times be within the Stockholder’s control; provided, further, that by making the representations in this Section 3.6, the Stockholder does not agree to hold any of the Exchange Shares for any minimum or other specific term and reserves the right to dispose of the Exchange Shares at any time in accordance with applicable securities Laws (subject to any transfer restrictions imposed under Section 10(b) of the Permanent Warrant), (b) will not sell or otherwise dispose of any of the Exchange Shares, except in compliance with the registration requirements or exemption provisions of the Securities Act and any applicable U.S. state securities Laws and (c) was given the opportunity to ask questions and receive answers concerning the terms and conditions of the Exchange and to obtain any additional information which the Company possesses or can acquire without unreasonable effort or expense.
5
3.7 No Brokers or Finders. In connection with the Exchange and the other transactions contemplated hereby, none of the Stockholder, its affiliates, or any of its or their respective officers, directors, employees or agents has employed any broker or finder or incurred any liability for any financial advisory fees, brokerage fees, commissions or finder’s fees, in each case, for which the Company would be liable.
ARTICLE 4
MISCELLANEOUS
4.1 Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given on (a) the date of delivery if delivered personally, or if by email, upon delivery (provided that no auto-generated error or non-delivery or similar message is generated in response thereto), (b) the first (1st) business day following the date of dispatch if delivered utilizing a next-day service by a recognized next-day courier or (c) the earlier of confirmation of receipt or the fifth (5th) business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice:
If notice is given to the Company:
New York Community Bancorp, Inc.
102 Duffy Avenue
Hicksville, New York 11801
Attention: Bao Nguyen,
Senior Executive Vice President, General Counsel and Chief of Staff
Email: *****
With a copy (which shall not constitute notice) to:
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, NY 10017
Attention: Sven Mickisch; Matthew Nemeroff; Timothy Gaffney
E-mail: Sven.Mickisch@stblaw.com; Matthew.Nemeroff@stblaw.com;
Timothy.Gaffney@stblaw.com
If notice is given to the Stockholder:
[•]
[•]
Attention: [•]
Email: [•]
6
With a copy (which shall not constitute notice) to:
[•]
[•]
Attention: [•]
Email: [•]
4.2 Entire Agreement. This Agreement (including the documents and the instruments referred to herein), together with the Investment Agreement, the Registration Rights Agreement and any other agreement entered into by the parties hereto (or their affiliates) in connection with the entry hereof, constitute the entire agreement among the parties and supersede all prior agreements and understandings, written, oral or otherwise, among the parties with respect to the subject matter hereof.
4.3 Governing Law; Jurisdiction.
(a) This Agreement shall be governed by, construed and enforced in accordance with the laws of the State of Delaware, without regard to any applicable conflicts of law principles.
(b) Each party agrees that it will bring any action, suit, litigation, dispute or proceeding in respect of any claim arising out of or related to this Agreement or the transactions contemplated hereby exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware, or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal or state court of competent jurisdiction located in the State of Delaware (the “Chosen Courts”), and, solely in connection with claims arising under this Agreement or the transactions that are the subject of this Agreement, (i) irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (ii) waives any objection (A) to laying venue in any such action, suit, litigation, dispute or proceeding in the Chosen Courts and (B) that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any party and (iii) agrees that service of process upon such party in any such action, suit, litigation, dispute or proceeding will be effective if notice is given in accordance with Section 4.1.
4.4 Waiver Of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE HEREUNDER IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND, THEREFORE, EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE EXTENT PERMITTED BY LAW AT THE TIME OF INSTITUTION OF THE APPLICABLE LITIGATION, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, SUIT, LITIGATION, DISPUTE OR PROCEEDING, DIRECTLY OR INDIRECTLY, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY SUCH ACTION, SUIT, LITIGATION, DISPUTE OR PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) IT MAKES THIS WAIVER VOLUNTARILY, AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 4.4.
7
4.5 Fees and Expenses. Each party shall pay all of its own costs, fees and expenses relating to the transactions contemplated under this Agreement.
4.6 Amendments and Waivers. Any term or provision hereof may be amended, terminated or waived with the written consent of the Company and the Stockholder.
4.7 Counterparts. This Agreement may be executed in counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not sign the same counterpart.
4.8 Disclosure. At or prior to 9:00 a.m., New York City time, on the first business day after the date hereof, the Company shall file with the SEC a current report on Form 8-K announcing the Exchange and the Other Exchanges contemplated by the Other Exchange Documents in form and substance mutually agreed by the parties hereto.
4.9 Expiration Date. Notwithstanding anything herein to the contrary, if the Closing has not occurred by 5:00 p.m. (New York City time) on the second (2nd) business day following the date hereof, unless otherwise mutually agreed in writing to by the parties hereto, either party shall have the right (but not the obligation) to terminate this Agreement by delivering a written notice to that effect to each other party hereto and without liability of any party to any other party.
4.10 Stockholder Acting Independently.
(a) The obligations of the Stockholder under this Agreement are several and not joint with the obligations of any Other Stockholder under any Exchange Document, and the Stockholder shall not be responsible in any way for the performance of the obligations of any Other Stockholder under any Exchange Document.
(b) Nothing contained herein or in any Exchange Document, and no action taken by the Stockholder pursuant hereto or thereto, shall be deemed to constitute the Stockholder and any Other Stockholder as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Stockholder and any Other Stockholder are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any Exchange Document, and the Company acknowledges that the Stockholder and the Other Stockholders are not acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any Exchange Document.
(c) The Company and the Stockholder confirm that the Stockholder has independently participated in the negotiation of the transactions contemplated hereby with the advice of its own counsel and advisors. The Stockholder shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any Other Stockholder to be joined as an additional party in any proceeding for such purpose.
8
4.11 No Lock-Up Violation. The Company acknowledges and agrees that (a) the Exchange does not violate the transfer restrictions imposed in Section 10(b) of the Permanent Warrant, (b) it will not take a position contrary to the foregoing Section 4.11(a) and (c) on September 10, 2024, it shall use reasonable best efforts to cause its transfer agent to remove from the Exchange Shares and any other securities issued or issuable to the Stockholder pursuant to the Investment Agreement the portion of the restrictive legend solely with respect to Section 10(b) of the Permanent Warrant.
[Signature Page Follows]
9
IN WITNESS WHEREOF, the undersigned have caused their duly authorized officers to execute and deliver this Agreement as of the day and year first written above.
| New York Community Bancorp, Inc. | [STOCKHOLDER] | |||
|
|
| |||
| Name: | Name: | |||
| Title: | Title: | |||
[Signature Page to Share Exchange Agreement]
2;^=J\N[,"[W]RJ[.U@B/[VS?FE.9\4''' MTJVVDZ
M$*9L;&_.I$ N:S]5LU@>?XC)R_(F2L)8/&8\2;@[TFYLQ$'D^D( C!OCZ063
M#2E6N ^ J!$N3*%PP_2.) *0@?0W(@2TY2?UJ]G0^*NXOR %N=='O=8&@&Y
ML?@]A7BZOL2%OBO67X"5?BO!>)$2##!.,":($X^G^E [2!B/*2H!/S&!/VN?
MP_ :/Q&$]E'(MV^^+9\;:_^TJTY5<0Z#&L;CT"P4A(,.4[GP7X=?4W
M:Q0$?50:YR"C5.1='6)#"U ?-_#P3(;@ !T*>!G4Y4)\ #[SY>+947:G.>2\
M(&8TUA!N:-MLZ/^B>#AU;[;!;D[WMFWVEKOYW-O28-W68+76\MSRI#4V9?)+
M5H3E0#^["$F_)//